USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: GAMMA THERAPEUTICS, INC.
Address: 2611 SW 3RD AVE, STE 280P
PORTLAND, OR 97201-4957
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $514,223.00 1
SBIR Phase II $1,048,970.00 1

Award List:

Venous Thromboembolism Risk Marker Assay

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: David H. Farrell
Award Amount: $514,223.00
Abstract:
DESCRIPTION (provided by applicant): The application's broad, long-term objectives are to develop a rapid, high-throughput clinical assay for 3' fibrinogen that will be used to assess the risk of a patient developing venous thromboembolism. This assay will guide clinical management, particularly… More

Venous Thromboembolism Risk Marker Assay

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: David H. Farrell – 503-494-8602
Award Amount: $1,048,970.00
Abstract:
DESCRIPTION (provided by applicant): The application's broad, long-term objectives are to develop a rapid, high-throughput clinical assay for 3' fibrinogen that will be used to assess the risk of a patient developing venous thromboembolism. This assay willguide clinical management,… More